NCT04500535View on ClinicalTrials.gov

A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy

UnknownOBSERVATIONAL
Enrollment

698

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
Lung Cancer
Trial Locations (1)

75248

Local Institution - 0001, Paris

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04500535 - A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy | Biotech Hunter | Biotech Hunter